The role of government and private insurers in guiding and implementing pharmacoeconomic analyses.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 1998 AND VI 13 AND IP 4
Results: 8
1
2
The (near) equivalence of cost-effectiveness and cost-benefit analyses. Fact or fallacy?
- Published in:
- 1998
- By:
- Publication type:
- journal article
3
An introduction to Markov modelling for economic evaluation.
- Published in:
- 1998
- By:
- Publication type:
- journal article
4
The Use of QALY and Non-QALY Measures of Health-Related Quality of Life: Assessing the State of the Art.
- Published in:
- PharmacoEconomics, 1998, v. 13, n. 4, p. 411, doi. 10.2165/00019053-199813040-00004
- By:
- Publication type:
- Article
5
Valuation of EuroQOL (EQ-5D) health states in an adult US sample.
- Published in:
- 1998
- By:
- Publication type:
- journal article
6
Antidepressant selection and use and healthcare expenditures. An empirical approach.
- Published in:
- 1998
- By:
- Publication type:
- journal article
7
Pharmacoeconomic analysis of 3 treatment strategies for cytomegalovirus retinitis in patients with AIDS.
- Published in:
- 1998
- By:
- Publication type:
- journal article
8
Evaluation of the potential clinical and economic effects of bodyweight stabilisation with acarbose in patients with type 2 diabetes mellitus. A decision-analytical approach.
- Published in:
- 1998
- By:
- Publication type:
- journal article